Atlas Trials

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Clinical trial NCT03771404 · UNKNOWN

Trial details

NCT number
NCT03771404
Sponsor
Hellenic Oncology Research Group
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2018-01-05
Primary completion
2021-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.